Janney Montgomery Scott LLC Sells 366 Shares of Doximity, Inc. (NASDAQ:DOCS)

Janney Montgomery Scott LLC decreased its holdings in Doximity, Inc. (NASDAQ:DOCS) by 1.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 19,225 shares of the company’s stock after selling 366 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Doximity were worth $838,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Swedbank AB acquired a new stake in shares of Doximity during the 1st quarter worth $91,673,000. Capital World Investors grew its stake in Doximity by 250.7% during the first quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock worth $46,143,000 after buying an additional 1,225,707 shares in the last quarter. William Blair Investment Management LLC increased its holdings in Doximity by 15.8% in the 2nd quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock valued at $179,122,000 after buying an additional 873,682 shares during the period. Janus Henderson Group PLC raised its position in shares of Doximity by 33.5% in the 1st quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock valued at $66,594,000 after buying an additional 621,590 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its holdings in shares of Doximity by 7.1% during the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock worth $163,709,000 after acquiring an additional 387,200 shares during the period. Institutional investors own 87.19% of the company’s stock.

Doximity Stock Performance

Shares of NASDAQ:DOCS opened at $49.40 on Friday. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The firm has a market cap of $9.17 billion, a PE ratio of 56.78, a price-to-earnings-growth ratio of 4.51 and a beta of 1.30. The firm’s fifty day moving average is $43.40 and its 200-day moving average is $34.18.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on DOCS shares. Barclays lifted their price objective on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday, November 11th. Truist Financial boosted their price target on Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a report on Thursday. The Goldman Sachs Group began coverage on Doximity in a research note on Friday. They issued a “neutral” rating and a $58.00 price objective on the stock. Evercore ISI boosted their target price on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, Bank of America raised their price target on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a research note on Monday, October 7th. Eleven analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $51.07.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.